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Abstract: Acacia mearnsii De Wild. (Fabaceae) is a medicinal plant used in the treatment 
of microbial infections in South Africa without scientific validation of its bioactivity and 
toxicity. The antimicrobial activity of the crude acetone extract was evaluated by both agar 
diffusion and macrobroth dilution methods while its cytotoxicity effect was assessed with 
brine shrimp lethality assay. The study showed that both bacterial and fungal isolates were 
highly  inhibited  by  the  crude  extract.  The  MIC  values  for  the  gram-positive  bacteria  
(78.1–312.5)  µg/mL,  gram-negative  bacteria  (39.1–625)  µg/mL  and  fungal  isolates  
(625–5000) µg/mL differ significantly. The bacteria were more susceptible than the fungal 
strains  tested.  The  antibiosis  determination  showed  that  the  extract  was  more  (75%) 
bactericidal  than  bacteriostatic  (25%)  and  more  fungicidal  (66.67%)  than  fungistatic 
(33.33%). The cytotoxic activity of the extract was observed between 31.25 µg/mL and 
500 µg/mL and the LC50 value (112.36 µg/mL) indicates that the extract was nontoxic in 
the brine shrimp lethality assay (LC50 > 100 μg/mL). These results support the use of 
A. mearnsii  in  traditional  medicine  for  treatment  of  microbial  infections.  The  extract 
exhibiting  significant  broad  spectrum  antimicrobial  activity  and  nontoxic  effects  has 
potential to yield active antimicrobial compounds.  
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1. Introduction 
In Africa, the use of remedies derived from plants in traditional health practices is common and 
widespread [1] even before the introduction of antibiotics and other modern drugs [2]. While more than 
80% of the world’s population still depends upon the traditional medicines for various diseases [3,4], 
Patel and Coogan [5] indicated that natural products have been used worldwide for medicinal purposes 
for thousands of years. Being nontoxic and easily affordable, today, there has been resurgence in the 
consumption and demand for medicinal plants [6] resulting from bacterial resistance to currently used 
antibiotics  becoming  a  public  health  concern  [7],  rising  costs  of  prescription  drugs  and  the 
bioprospecting of new plant-derived drugs [8]. Though only 5–15% of the estimated 250,000 higher 
plants in the world [9] have been studied for a potential therapeutic value [10] and represent a potential 
source of new anti-infective agents [11,12], a large number remains to be investigated since the search 
for antimicrobial agents is largely concentrated on lower plants, fungi and bacteria.  
Since the development of new compounds and antimicrobial agents for the treatment of microbial 
infections has recently become of increasing interest [13], the trend of using natural products has 
increased and the active plant extracts are frequently screened for new drug discoveries  [14]. The 
effects of plant extracts on microorganisms have been studied by a very large number of researchers in 
different parts of the world [15–17]. The presence of antibacterial, antifungal and other biological 
activities have also been demonstrated in extracts of different plant species used in traditional medicine 
practices [18–20]. On this basis, several reports have indicated that antimicrobial activity of crude 
plant extracts and the bioassay-guided fractionation of those extracts yielded active principles [21,22]. 
Although there is a growing interest in correlating the phytochemical constituents of a medicinal 
plant with its pharmacological activity [23,24], the toxicological effects of most of these crude extracts 
are often overlooked based on the facts that plant medicines have better compatibility with the human 
body  and  produce  fewer  side  effects  [25].  However,  to  forestall  adverse  effects,  sometimes  
life-threatening, allegedly arising consequential to taking herbal products or traditional medicines [26,27], 
cytotoxicity testing, an integral component of the biological evaluation of pharmacologically important 
materials and an essential part of standard screening procedures, becomes essential. Since toxicological 
evaluation of a plant extract seeks to determine its possible collateral effects to ensure the safety of its 
use, brine shrimp larvae, being sensitive to toxic substances, are commonly used for toxicity assays in 
pharmacology.  The  ratio  between  dead  larvae  (no  motility)  and  living  larvae  (high  motility)  in 
comparison  to  a  control  without  any  toxic  substance  is  used  to  estimate  the  toxicity  of  the  test 
substances [28]. 
Acacia is a pantropical and subtropical genus with species abundant throughout Australia, Asia, 
Africa  and  America.  The  plant  Acacia  mearnsii  De  Wild.  (Fabaceae),  previously  known  as 
Racosperma mearnsii [29] and commonly known as Black Wattle tree, is a short medium lived woody 
perennial  and  spreading  tree,  about  15  m  high  with  smooth  and  greenish-brown  bark  on  young 
branches  which  are  blackish  and  rough  on  trunk.  The  young  branchlets  are  downy.  While  it  is 
widespread and common in lowlands, open forest, heathy woodland and on cleared land, particularly 
on dry, shallow soils [30], it grows in open forest, woodland or tussock grassland, in gullies or on 
hillsides, in sandy or gravelly clay soils [31]. It has inflorescence globular with 20–30 tiny pale yellow 
flowers. Pods, dark brown to black in color, are more or less straight, 5–10 cm long, 5–8 mm wide and Int. J. Mol. Sci. 2012, 13  4257 
 
 
strongly constricted between seeds [30]. Though little is known of the pharmacological importance of 
this plant, its phytochemical screening showed that the total phenolic content correlated well with the 
antioxidant activity of the extracts [32]. Since this plant is ethobotanically relevant in the treatment of 
microbial infections locally and scientific report on its pharmacological importance is limited, this 
study was aimed at assessing the antimicrobial and toxicity activities of the crude acetone stem bark 
extract of A. mearnsii in vitro to justify its ethnotherapeutic usage. 
2. Results and Discussion 
In this study, the antibacterial, antifungal and cytotoxicity activity of the crude acetone extract of 
the  A.  mearnsii  was  determined  against  twelve  bacterial  strains,  twelve  fungal  isolates  and  brine 
shrimps respectively. The crude extract  showed varied degrees  of antibacterial  activity  against all 
bacteria tested (Table 1).  
Table 1. Bacterial susceptibility to different concentrations of acetone stem bark extract of 
A. mearnsii. 
Tested bacterial isolates 
Average inhibition zones produced by 100 µ L of each 
concentration of antibacterial agents (± 1.0 mm) 
Erythromycin   Crude acetone extract of A. mearnsii 
  50   20,000   10,000   5000   2500   1250   625  
  µ g/mL 
Proteus vulgaris KZN  32  20  17  15  15  13  0 
Staphylococcus aureus OK1   31  19  14  0  0  0  0 
Enterococcus faecalis KZN  0  20  16  14  0  0  0 
Klebsiella pneumoniae KZN  14  22  20  18  16  15  14 
Proteus vulgaris CSIR 0030  38  35  33  27  23  20  19 
Bacillus cereus (ATCC 10702)  30  24  22  20  17  16  14 
Escherichia coli (ATCC 25922)  13  22  20  18  16  15  15 
Bacillus pumilus (ATCC 14884)  16  22  19  18  18  18  16 
Salmonella typhi (ATCC 13311)  13  27  24  20  16  14  0 
Serratia marcescens(ATCC 9986)  18  27  24  22  21  20  18 
Klebsiella pneumoniae (ATCC 10031)  30  22  20  18  17  16  15 
Pseudomonas aeruginosa (ATCC 19582)   37  20  18  16  14  13  0 
Though both gram-positive and gram-negative were highly inhibited, the crude extract was most 
active against Proteus vulgaris CSIR 0030 inhibited at a minimum inhibitory concentration (MIC) of 
39.1 µg/mL in comparison to other tested isolates. The MIC values for the gram-positive bacteria 
ranged  78.1–312.5  µg/mL  while  those  of  gram-negative  bacteria  ranged  from  39.1–625  µg/mL  
(Table 2). The result of the agar diffusion and macrobroth dilution assay are complementary. Results  
showed  susceptibility  patterns  of  the  bacteria  dependent  on  extract  concentration.  At  the  highest  
concentration (2000 µg/mL) of extract, the inhibition zones for all the bacteria ranged between 19 and 
35 ±  1.0 mm. While Proteus vulgaris CSIR 0030 with the least MIC value (39.1 µg/mL) had highest 
inhibition zones (35 ±  1.0 mm) in comparison to those of other isolates, Staphylococcus aureus OK1 
with  the  following  lowest  MIC  value  (78.1  µg/mL)  had  the  least  zone  (19  ±   1.0  mm),  and  Int. J. Mol. Sci. 2012, 13  4258 
 
 
Escherichia coli (ATCC 25922) and Serratia marcescens (ATCC 9986) with the highest MIC value 
(625  µg/mL)  had  intermediate  zones  of  inhibition  (22  and  27  ±   1.0  mm,  respectively).  With  the 
exception  of  Proteus  vulgaris  KZN,  Staphylococcus  aureus  OK1,  Enterococcus  faecalis  KZN, 
Salmonella typhi (ATCC 13311) and Pseudomonas aeruginosa (ATCC 19582), other bacteria had 
inhibition zones at the least concentration (625 µg/mL) tested. 
Table 2. Degree of antibacterial activities of acetone stem bark extract of A. mearnsii. 
Tested bacterial isolates 
Erythromycin  A. mearnsii 
MIC (µ g/mL)  MIC (µ g/mL)  MBC (µ g/mL)  MICindex 
Proteus vulgaris KZN   12.5  312.5  625  2 
Staphylococcus aureus OK1   0.1953  78.1  78.1  1 
Enterococcus faecalis KZN   12.5  156.3  625  4 
Klebsiella pneumoniae KZN   12.5  312.5  625  2 
Proteus vulgaris CSIR 0030   0.048  39.1  156.3  4 
Bacillus cereus (ATCC 10702)   0.0977  156.3  312.5  2 
Escherichia coli (ATCC 25922)   0.3906  625  625  1 
Bacillus pumilus (ATCC 14884)   12.5  312.5  312.5  1 
Salmonella typhi (ATCC 13311)   6.25  156.3  156.3  1 
Serratia marcescens (ATCC 9986)   3.125  625  625  1 
Klebsiella pneumoniae (ATCC 10031)   0.09765  156.3  156.3  1 
Pseudomonas aeruginosa (ATCC 19582)   0.1953  156.3  625  4 
The antifungal activity of the extract showed that the fungal isolates were susceptible at varied 
concentrations. The MIC values ranged 625–5000 µg/mL. The asexually reproducing fungi exhibited 
higher MIC values than the non-spore forming fungi (Table 3). While the MBC values for the bacterial 
isolates  ranged  between  78.1  µg/mL  and  625  µg/mL,  the  fungal  MFC  values  ranged  between  
625 µg/mL and 20,000 µg/mL. Mechanism of antibiosis determination showed that the extract was 
more (75%) bactericidal than being bacteriostatic (25%) and more fungicidal (66.67%) than being 
fungistatic (33.33%). While the bacteria were more susceptible to the erythromycin, used as control, 
with  zones  of  inhibition,  except  for  Enterococcus  faecalis  KZN,  ranging  from  13  ±   1.0  mm  to  
38 ±  1.0 mm and MIC values ranging 0.048–12.5 µg/mL, the crude extract was not found to be 
ineffective  against  the  microbial  isolates  test.  Comparatively,  the  bacterial  strains  were  more 
susceptible than the fungal strain.  
Interacting the extract and brine shrimps at the concentrations used for the antimicrobial assay for 
the  plant  resulted  in  the  death  of  the  shrimps  within  15  min.  The  assay  was  repeated  at  low 
concentrations ranging between 0.9765 µg/mL and 500 µg/mL. Mortality of the brine shrimps was 
noticed in the experimental group but the control group remained unchanged at the same time. The 
number of surviving brine shrimps in each vial was counted and the results were noted. The percent of 
mortality  of  the  shrimp  was  calculated  for  every  concentration  of  the  test  sample.  The  cytotoxic 
activity of the extract was observed between 31.25 µg/mL and 500 µg/mL. At 500 µg/mL, all the brine 
shrimps were killed and none was killed at 31.25 µg/mL after 24 h incubation period (Table 4). The 
mortality rate of the brine shrimps was found to increase with the increase in concentration of the 
sample. It is evident from the results of the brine shrimp lethality assay that the crude extract with the Int. J. Mol. Sci. 2012, 13  4259 
 
 
LC50 being 112.36 µg/mL having the highest levels of toxicity (100%) death at 500 μg/mL was non 
toxic (LC50 > 100 μg/mL). 
Table 3. Antifungal activities of acetone stem bark extract of A. mearnsii. 
Tested fungal isolates 
Antifungal activities of A. mearnsii 
MIC (µ g/mL)  MFC (µ g/mL)  MICindex 
Candida krusei  1250  2500  2 
Candida albicans  625  1250  2 
Candida rugosa  625  625  1 
Aspergillus niger  5000  20,000  4 
Aspergillus terreus  5000  20,000  4 
Aspergillus flavus  5000  20,000  4 
Penicillium notatum  5000  20,000  4 
Absidia corymbifera  625  625  1 
Fusarium sporotrichioides  625  625  1 
Trichophyton tonsurans  2500  5000  2 
Candida glabrata (ATCC 2001)  625  625  1 
Trichophyton mucoides (ATCC 201382)  2500  5000  2 
Table 4. Cytotoxicity effects of acetone stem bark extract of A. mearnsii on brine shrimps. 
Conc. of 
extract 
(µ g/mL) 
Test 1  Test 2  Test 3 
Av. No. of 
shrimp alive 
(Sample) 
Av. No. of 
shrimp alive 
(Control) 
% 
Mortality 
Log. of 
conc. 
LC50 
µ g/mL 
31.25  0  0  0  0  10  0  1.495 
 
62.5  5  4  4  4.33  10  43.3  1.796 
 
125  7  8  8  7.66  10  76.6  2.097  112.36 
250  9  10  9  9.33  10  93.33  2.398 
 
500  10  10  10  10  10  100  2.699 
 
Resulting from the global increase in microbial resistance is a need to assess the antimicrobial 
activity of several medicinal plants with increased spectrum, potency and novel mechanisms of action 
which  may  be  systemically  active  and  offer  new  hope  for  improved  therapeutic  outcomes. 
Consequently, in addition to the significant antimicrobial activity exhibited by A. mearnsii, the varied 
degree of antimicrobial activity of the extract could be due to the nature and level of antimicrobial 
agents present in the plant, their mode of action and the typical differences in the microbial cell walls 
between the strains [33] as well as the synergistic effects of different phytochemicals present in the 
plant. The antimicrobial activity at relatively minimal concentrations of the extract could be attributed 
to the active phytochemical compounds present in the extract at different concentrations and potent 
enough  to  inhibit  or  kill  microbial  agents.  Though  there  is  a  dearth  of  scientific  reports  on  the 
pharmacological  importance  of  this  plant,  Olajuyigbe  and  Afolayan  [34]  earlier  indicated  that  its 
aqueous  and  ethanolic  extracts  exhibited  significant  antibacterial  activities.  The  pronounced 
antibacterial effect of the extract in both gram-negative and gram-positive bacteria may be attributed to 
its ability to damage the different cell walls to allow the active compounds to adsorb, diffuse, penetrate 
and  interact  with  the  affected  target  sites  as  earlier  indicated  by  Olajuyigbe  and  Afolayan  [17]. 
Furthermore, the significant multifarious effects of the extract on the fungal isolates could be due to Int. J. Mol. Sci. 2012, 13  4260 
 
 
the differences in their morphology, disruption of membrane [35] or cell wall integrity [36], inhibition 
of mycelia growth [37], high potential to block morphogenetic transformation [38], indirect inhibition 
of cell wall synthesis [39] and spore germination [40]. Hence, the degree of the fungicidal effects of 
the extract depends on its ability to significantly cause either, or all, of these processes.  
The in vivo brine shrimp lethality test is a simple way of screening and fractionating physiologically 
active plant extract. It is based on whether the brine shrimp are dead or alive at the end of the test or on 
the ability to kill laboratory-cultured Artemia nauplii [41]. The LC50 (112.36 µg/mL) of this extract is 
in agreement with the earlier report of [42] which indicated that several extracts containing physiological 
active principles derived from natural products has LC50 ≤ 1000 μg/mL using brine shrimp bioassay. 
However, in agreement with Moshi et al. [43], the crude acetone extract was nontoxic.  
Despite  a  great  lack  of  investigations  linking  phytochemical  constituents,  pharmacology  and 
toxicological activity of many medicinal plants used in ethnomedicine, the pharmaceutical industry is 
moving away from drug discovery or screening towards medicinal plant materials which have become 
the  subject  of  public  attention.  In  view  of  the  fact  that  there  is  a  relationship  between  the 
pharmacological  activity  and  toxicity  of  natural  products  from  plants,  the  degree  of  antimicrobial 
activity and toxicity exhibited by A. mearnsii show a good relationship. While Schmitz et al. [44] 
indicated that the compounds that showed activity in the brine shrimp could be associated to some 
extent  to  the  potency  of  the  pharmacologically  active  principles  in  natural  products,  the  varied 
antimicrobial activity exhibited by this extract may be attributed to its toxicity level resulting from the 
synergistic activity of the various phytochemicals present in the plant. An increase in the toxicity of the 
plant could possibly result in higher antimicrobial effects.  
In addition, the significance of the inhibitory, bactericidal and fungicidal activities of this extract 
may not  be underestimated.  Since  in  vitro antimicrobial susceptibility  testing assesses  the relative 
susceptibility of microbial pathogens to selected therapeutic agents to optimize treatment of infections 
in clinical settings, determination of the microbicidal activity of these antimicrobial agents against an 
infecting organism may be useful in guiding therapy for serious infections especially when the host 
immune defense is  compromised. The high percentages  of the bactericidal and fungicidal  activity 
activities  of  this  extract  at  high  concentrations  showed  the  potentials  of  its  active  compounds  to 
minimize the spread of an infecting organism from the site of infection and kill invading pathogens.  
In view of the fact that systemically active antimicrobial agents with increased spectrum and potency 
may offer new hope for improved therapeutic outcomes in both competent and immunocompromised 
individuals, a “cidal” regimen [45–48], for which Acacia mearnsii is an indicator, would be preferable. 
This, however, may justify the ethnotherapeutic relevance of this plant in the treatment of microbial 
infections in South Africa. 
3. Experimental Section  
3.1. Collection of Plant Material 
The bark materials of A. mearnsii De Wild were collected in August 2010, from the plant growing 
within the University of Fort Hare campus in Alice, South Africa. The plant was authenticated in the Int. J. Mol. Sci. 2012, 13  4261 
 
 
Department of Botany and a voucher specimen was prepared and deposited in the Griffen Herbarium 
of the University. 
3.2. Extract Preparation 
The bark sample was air-dried at room temperature, pulverized in a mill (Christy Lab Mill, Christy 
and Norris Ltd.; Process Engineers, Chelmsford, UK) and stored in a sterile air-tight container for 
further use. The extract of the bark was prepared in accordance to the description of Basri and Fan [49]. 
About 100 g of the pulverized sample was steeped in 500 mL of acetone for 72 h with shaking (Stuart 
Scientific Orbital Shaker, UK). The plant material was extracted for two other consecutive times. The 
extracts were combined, filtered through Whatman No. 1 filter paper and concentrated under reduced 
pressure at 40 ° C using a rotary evaporator (Laborarota 4000 efficient, Heldolph, Germany). The crude 
extract collected was allowed to dry at room temperature to a constant weight of 21.4 g. The extract 
was redissolved in acetone to the required concentrations for the bioassay analysis.  
The  reconstituted  crude  acetone  extract  solution  was  sterilized  by  filtering  through  0.45  μm 
membrane filter. The extract was tested for sterility after membrane filtration by introducing 2 mL of 
the extract into 10 mL of sterile nutrient broth and incubated at 37 ° C for 24 h. A sterile extract was 
indicated by the absence of turbidity in the broth after the incubation period. 
3.3. Test Organisms 
The bacterial isolates used in this study included Escherichia coli (ATCC 25922), Bacillus cereus 
(ATCC 10702), Proteus vulgaris KZN, Serratia marcescens (ATCC 9986), Pseudomonas aeruginosa 
(ATCC 19582), Enterococcus faecalis KZN, Klebsiella pneumoniae (ATCC 10031), Proteus vulgaris 
CSIR 0030, Bacillus pumilus (ATCC 14884), Klebsiella pneumoniae KZN, Staphylococcus aureus 
OK1  and  Salmonella  typhi  (ATCC  13311).  The  fungal  isolates  included  Candida  krusei,  
Candida  albicans,  Candida  rugosa,  Candida  glabrata  (ATCC  2001),  Absidia  corymbifera,  
Fusarium  sporotrichioides,  Trichophyton  tonsurans,  Trichophyton  mucoides  (ATCC  201382), 
Penicillium notatum, Aspergillus niger, Aspergillus terreus and Aspergillus flavus. These organisms 
were obtained from the Department of Biochemistry and Microbiology, University of Fort Hare, Alice, 
South Africa. The organisms were maintained on nutrient broth, nutrient agar (Biolab), potato dextrose 
agar and sabouraud dextrose broth. The antibacterial assays were carried out using Mueller Hinton II 
agar  and  broth  (Biolab).  The  antifungal  assays  were  carried  out  using  sabouraud  dextrose  agar  
and broth. 
3.4. Preparation of Inocula 
For the bacterial inoculums preparation, the inoculum of each test bacterial strains was prepared 
using the colony suspension method [50]. Colonies picked from 24 h old cultures grown on nutrient 
agar were used to make suspensions of the test organisms in saline solution to give an optical density 
of approximately 0.1 at 600 nm. The suspension was then diluted 1:100 by transferring 0.1 mL of the 
bacterial suspension to 9.9 mL of sterile nutrient broth before use. The density of bacterial suspension Int. J. Mol. Sci. 2012, 13  4262 
 
 
for susceptibility test was finally determined by comparison with 0.5 McFarland standard of Barium 
sulphate solution [51]. 
For the fungal inoculums preparation, spore suspension for fungal bioassay was prepared according 
to the procedure of Murugan et al. [52] as modified. Briefly, 1 cm
2 of seven day old spore producing 
cultures was dropped in sterile distilled water and vortexed for 30 s to release the fungal spores. The 
spore  density  of  each  fungus  was  adjusted  with  spectrophotometer  (A595nm)  to  obtain  a  final 
concentration of approximately 10
5 spores/mL. For the Candida spp., the inocula were prepared by 
adding 1 mL of overnight Candida cultures to 9 mL of sabouraud dextrose broth to yield 10
4 colony 
forming units (CFU) per microliter of the inoculum. 
3.5. Antibiotic Susceptibility Testing—Agar Diffusion Method  
The  antibiotic  susceptibility  testing  was  determined  using  the  modified  Kirby-Bauer  diffusion 
technique [51] by swabbing the Mueller-Hinton agar (MHA) (Oxoids, UK) plates with the resultant 
saline suspension of each strain. Wells were then bored into the agar medium with heat sterilized 6 mm 
cork borer. The wells were filled with 100 µL of different concentrations (625 µg/mL, 12,500 µg/mL, 
2500 µg/mL, 5000 µg/mL, 10,000 µg/mL and 20,000 µg/mL) of the crude extract and 50 µg/mL of 
erythromycin antibiotic taking care not to allow spillage of the solutions onto the agar surface. The 
determinations were done in duplicates. After 24 h of incubation, the diameter of the inhibition zones 
of  the  extract  and  the  antibiotic  was  measured  and  interpreted  using  the  CLSI  zone  diameter 
interpretative standards [53]. 
3.6. Macrobroth Dilution for Minimum Inhibitory Concentration (MIC) 
Minimum inhibitory concentration (MIC) of the extract defined as the lowest concentration which 
resulted in maintenance or reduction of inoculums viability [54] was determined by serial tube dilution 
technique [55] against the bacterial and fungal isolates. For antibacterial assay, different concentrations 
of the extract ranging from 20 µg/mL to 10,000 µg/mL were prepared by serial dilutions in Mueller 
Hinton broth medium. Different concentrations of erythromycin (0.0122–50 µg/mL), used as positive 
control, were also prepared by serial dilution in Mueller Hinton broth. The tubes were inoculated with 
100 µL of each of the bacterial strain. Blank Mueller Hinton broth was used as negative control.  
For the antifungal assay, different concentrations of the extract ranging between 19.53 µg/mL and 
40,000 µg/mL were prepared in sabouraud dextrose broth by serial dilutions. Each broth concentration 
was inoculated with 100 µL of the prepared fungal spores’ solution. Two control tubes were included: 
one with spores and broth but no plant extract and one with broth and plant extract but no spores. The 
bacterial containing tubes were incubated aerobically at 37 ° C for 24 h. The fungal containing tubes 
were  incubated  at  27  ° C  for  3–5  days.  The  first  tube  in  the  series  with  no  visible  growth  after 
incubation period was taken as the MIC.  
3.7. Determination of Minimum Bactericidal and Fungicidal Concentrations (MBC/MFC) 
The MBC and MFC assays were carried out as described by Cheesbrough [56]. Here, fresh nutrient 
agar and sabouraud dextrose agar plates were inoculated with one loopful of culture taken from each of Int. J. Mol. Sci. 2012, 13  4263 
 
 
the first five broth cultures that showed no growth in the MIC tubes. While MBC assay plates were 
incubated for at 37 ° C for 24 h, MFC assay plates were incubated at 25 ° C for 3–5 days. After the 
incubation periods, the lowest concentration of the extract that did not produce any bacterial or fungal 
growth  on  the  solid  medium  was  regarded  as  MBC  and  MFC  values  for  this  extract  [57].  This 
observation was matched with the MIC test tube that did not show evidence of growth after 48 h of 
incubating the bacteria or spore germination for the fungi after five days of incubation. 
3.8. Determination of Mechanisms of Antibiosis (Bactericidal or Bacteriostatic) 
The mechanism of antibiosis of the extracts was calculated using the ratio of MBC/MIC (MFC/MIC) 
or MICindex as described by Shanmughapriya et al. [58] to elucidate whether the observed antibacterial 
effects  were bactericidal,  fungicidal, bacteriostatic or fungistatic. When  the ratio of MBC/MIC  or 
MFC/MIC was ≤2.0, the extract was considered bactericidal or otherwise bacteriostatic. If the ratio is 
≥16.0, the extract was considered ineffective.  
3.9. Brine Shrimp Lethality Test  
The brine shrimp lethality test using the larvae of brine shrimp nauplii, Artemia salina L. was 
carried out using the standard procedure [42,59]. For the extract sample, 4000 µg of the crude acetone 
extract  was  initially  dissolved  in  1  mL  of  pure  dimethyl  sulfoxide  (DMSO)  to  make  the  extract 
hydrophilic after which 3 mL of sterile distilled water was added to get a concentration of 1000 µg/mL 
of the extract used as a stock solution. Different concentrations (0.9765–500 µg/mL) of the extract 
were prepared from the stock solution by serial tube dilution technique in different vials. Ten nauplii 
were transferred into each vial using Pasteur pipettes and were not given food because hatched brine 
shrimp can survive for up to 48 h without food [60] as they still feed on their yolk-sac [28]. The control 
vials were prepared using DMSO only and the experiment was replicated three times. After 24 h of 
incubation,  the  vials  were  examined,  the  numbers  of  survivors  in  each  vial  were  counted  and 
percentages  of  deaths  were  calculated.  Larvae  were  considered  dead  if  they  did  not  exhibit  any 
observable movement during several seconds of observation. The extract is regarded as non-toxic if its 
LC50 is greater than 100 μg/mL in the brine shrimp lethality assay [43]. The mean mortality percentage 
and LC50 (lethal concentration for 50% of the population) were determined using statistical analysis 
and the graph of Logarithm of concentration against percent lethality [61]. 
4. Conclusions  
The results show that the acetone extract of A. mearnsii had a significant antimicrobial activity and 
no toxic effects on the brine shrimps. This activity may indicate the medicinal potential, suggests the 
broad  spectrum  antimicrobial  potential  and  validates  the  popular  use  of  this  plant  in  traditional 
medicine for the treatment of microbial infections by rural communities in South Africa since the 
extract was regarded as being nontoxic on brine shrimps. Int. J. Mol. Sci. 2012, 13  4264 
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